UHMWPE carrying estradiol to treat the particle-induced osteolysis - Processing and characterizing

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 2, 2009, Pages 496-505

  Liu, Aiqin ^a   Qu, Shuxin ^a   Chao, Mengmeng ^a   Zhu, Minhao ^a   Weng, Jie ^a   Zhou, Zhongrong ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

Author keywords

17 estradiol (E2); Hot press processing characterization; Ultra high molecular weight polyethylene (UHMWPE); Wear

Indexed keywords

ABRASIVE WEARS; CRYSTALLINITY; DRUG CARRIER; DRY FRICTION; ELONGATION AT BREAK; FRICTION COEFFICIENTS; HIGH MELTING POINT; HOT PRESS; HOT PRESS PROCESSING-CHARACTERIZATION; JOINT REPLACEMENT; OSTEOLYSIS; POTENTIAL APPLICATIONS; THERMAL ANALYSIS; UHMW-PE; ULTIMATE TENSILE STRENGTH; ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE (UHMWPE); WEAR; WEAR MECHANISMS; WEAR PERFORMANCE; YIELD STRENGTH;

FOURIER TRANSFORM INFRARED SPECTROSCOPY; FRICTION; FUNCTIONAL GROUPS; HYDROPHOBICITY; JOINT PROSTHESES; MECHANICAL PROPERTIES; MELTING POINT; MOLECULAR WEIGHT; POLYETHYLENES; PRESSES (MACHINE TOOLS); SPECTROSCOPIC ANALYSIS; SPECTROSCOPY; TENSILE STRENGTH; THERMOANALYSIS; THERMOPLASTICS; TRIBOLOGY;

NONMETALLIC MATRIX COMPOSITES;

ESTRADIOL; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MELTING POINT; OSTEOLYSIS; PROCESSING; TENSILE STRENGTH; THERMAL ANALYSIS; THERMOSTABILITY;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ESTRADIOL; MATERIALS TESTING; MODELS, CHEMICAL; OSTEOLYSIS; POLYETHYLENES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRESS, MECHANICAL; TEMPERATURE; TENSILE STRENGTH; WATER;

EID: 67650471762     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32120     Document Type: Article

References (45)

1. Kurtz SM, Muratoglu OK, Evans M, Edidin AA. Advances in the processing, sterilization, and crosslinking of ultra-high molecular weight polyethylene for total joint arthroplasty. Biomaterials 1999;20:1659-1688.
2. Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005;26:1271-1286.
3. Amstutz HC, Campbell P, Kossovsky N, Clarke IC. Mechanism and clinical significance of wear debris-induced osteolysis. Clin Orthop Res 1992;276:7-18.
4. Harris WH. The problem is osteolysis. Clin Orthop Res 1995; 311:46-53.
5. Willert HG, Bertram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 1990; 258:95-107.
6. Fruh HJ, Willmann G, Pfaff HG. Wear characteristics of ceramic-on-ceramic for hip endoprostheses. Biomaterials 1997;18:873-876.
7. Anissian HL, Stark A, Gustafson A, Good V, Clarke IC. Metal-on-metal bearing in hip prosthesis generates 100-fold less wear debris than metal-on-polyethylene. Acta Orthopaedica Scandinavica 1999;70:578-582.
8. Firkins PJ, Tipper JL, Ingham E, Stone MH, Farrar R, Fisher J. A novel low wearing differential hardness, ceramic-on-metal hip joint prosthesis. Journal of Biomechanics 2001;34:1291-1298.
9. Chiesa R, Tanzi MC, Alfonsi S, Paracchini L, Moscatelli M, Cigada A. Enhanced wear performance of highly cross-linked UHMWPE for artificial joints. J Biomed Mater Res 2000; 50:381-387.
10. Pruitt LA. Deformation, yielding, fracture and fatigue behavior of conventional and highly cross-linked ultra high molecular weight polyethylene. Biomaterials 2005;26:905-915.
11. Xiong DS. Friction and wear properties of UHMWPE composites reinforced with carbon fiber. Mater Lett 2005;59:175-179.
12. Xie XL, Tang CY, Chan KY, Wu XC, Tsui CP, Cheung CY. Wear performance of ultrahigh molecular weight polyethylene/ quartz composites. Biomaterials 2003;24:1889-1896.
13. Anderson BC, Bloom PD, Baikerikar KG, Sheares VV, Mallapragada SK. At-Cu-Fe quasicrystal/ultra-high molecular weight polyethylene composites as biomaterials for acetabular cup prosthetics. Biomaterials 2002;23:1761-1768.
14. Shi W, Dong H, Bell T. Wear performance of ion implanted ultra high molecular weight polyethylene. Surf Eng 2003; 19:279-283.
15. Rieu J, Pichat A, Rabbe LM, Rambert A, Chabrol C, Robelet M. Ion implantation effects on friction and wear of joint prosthesis materials. Biomaterials 1991;12:139-143.
16. von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Henschke F, Löer F, von Knoch M. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 2005;26:3549-3555.
17. Ren W, Li XH, Chen BD, Wooley PH. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-κB activity. J Orthopaed Res 2004; 22:21-29.
18. Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 2002;84:236-249.
19. Thadani PJ, Waxman B, Sladek E, Barmada R, Gonzalez MH. Inhibition of particulate debris-induced osteolysis by alendronate in a rat model. Orthopedics 2002;25:59-63.
20. Iwase M, Kim KJ, Kobayashi Y, Itoh M, Itoh T. A novel bisphosphonate inhibits inflammatory bone resorption in a rat osteolysis model with continuous infusion of polyethylene particles. J Orthopaed Res 2002;20:499-505.
21. Shanbhag AS, Hasselman CT, Rubash HE. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthopaed Relat Res 1997;344:33-43.
22. Harris SA, Tau KR, Turner RT, Spelsberg TC. Estrogen and progestins. In: Bilezikian JP, Raitz LG, Rodan GA, editors. Principles of Bone Biology. San Diego: Academic Press; 1996. p 507-520.
23. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 1997;186:489-495.
24. Holzer G, Einhorn TA, Majeska RJ. Estrogen regulation of growth and alkaline phosphatase expression by cultured human bone marrow stromal cells. J Orthopaed Res 2002; 20:281-288.
25. Disilvio L, Jameson J, Gamie Z, Giannoudis PV, Tsiridis E. In vitro evaluation of the direct effect of estradiol on human osteoblasts (HOB) and human mesenchymal stem cells (h-MSCs). Injury 2006;37:S33-S42.
26. Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK, Härkönen P. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 1998;22:201-209.
27. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC. 17β-estradiol-inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antisteoporotic effect of estrogens. J Clin Invest 1992;89:883-891.
28. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H Manolagas SC. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992;257:88-91.
29. Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL-6. RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15:49-60.
30. Astrand J, Aspenberg P. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening. J Orthopaed Res 2004;22:244-249.
31. Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Janvier P, Guicheux J, Zambelli PY, Bouler JM, Gauthier O. Calcium phosphate drug delivery system: Influence of local zoledronate release on bone implant osteointegration. Bone 2005; 36:52-60.
32. Peter B, Gauthier O, Laib S, Bujoli B, Guicheux J, Janvier P, van Lenthe GH, Muller R, Zambelli PY, Bouler JM, Pioletti DP. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats. J Biomed Mater Res A 2006;76:133-143.
33. Duan K, Fan YW, Wang RZ. Electrolytic deposition of calcium etidronate drug coating on titanium substrate. J Biomed Mater Res B 2005;72:43-51.
34. Zenios M, Nokes L, Galasko CSB. Effect of a bisphosphonate, disodiurn pamidronate, on the quasi-static flexural properties of Palacos R acrylic bone cement. J Biomed Mater Res B 2004;71:322-326.
35. Marti E, Kaisersberger E, Kaiser G, Ma WY. Netzsch Annual 2000: Thermoanalytical Characterization of Pharmaceuticals. Selb/Bayern: Netzsch-Geraetebau; 2000. p 90-93.
36. Buford A, Goswami T. Review of wear mechanisms in hip implants: Paper I - General. Mater Des 2004;25:385-393.
37. Otsuka M, Matsuda Y, Baig AA, Chhettry A, Higuchi WI. Calcium-level responsive controlled drug delivery from implant dosage forms to treat osteoporosis in an animal model. Adv Drug Deliv Rev 2000;42:249-258.
38. Spiegelberg S. Thermal transitions. In: Kurtz SM, editor. The UHMWPE Handbook. Ultra-High Molecular Weight Polyethylene in Total Joint Replacement. New York: Academic Press; 2004. p 266.
39. Johnson KL. Normal contact of elastic solids-Hertz theory. In: Johnson KL, editor. Contact Mechanics. Great Britain: Cambridge University Press; 1985. p 90.
40. Detlev Mohr, Michael Wolff, Thomas Kissel. Gamma irradiation for terminal sterilization of 17β-estradiol loaded poly-(D,L-lactide-co-glycolide) microparticles. J Controlled Release 1999;61:203-217.
41. Shirong G, Qingliang W, Dekun Zh, Hua Zh, Dangsheng X, Chuanhui H, Xiaolong H. Friction and wear behavior of nitrogen ion implanted UHMWPE against ZrO2 ceramic. Wear 2003;255:1069-1075.
42. Wang A, Essner A, Polineni VK, Stark C, Dumbleton JH. Lubrication and wear of ultrahigh molecular weight polyethylene in total joint replacements. Tribol Int 1998;31:17-33.
43. Zheng J, Zhou ZR. Friction and wear behavior of human teeth under various wear conditions. Tribol Int 2007;40:278-284.
44. Tong J, Ma YH, Arnell RD, Ren LQ. Luquan Rena. Free abrasive wear behavior of UHMWPE composites filled with wollastonite fibers. Compos A 2006;37:38-45.
45. Nusbaum HJ, Rose RM, Paul IL, Crugnola AM, Radin EL. Wear mechanisms for ultrahigh molecular weight polyethylene in the total hip prosthesis. J Appl Polym Sci 1979;23:777-789.